Alkem Oncology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cetuxa is administered as an intravenous infusion and is available as 100 mg (2 mg/mL) in a single-dose vial

United statesEnzene biosciencesAlkem oncologyEnzene biosciences limitedGlobal cancer observatoryDrugs controller general